Client Overview

A top 10 global pharmaceutical manufacturer sought to modernize its asset management and maintenance processes by migrating from a legacy system to IBM Maximo (Integrated with TrackWise Digital). Operating in a highly regulated GxP environment, the company needed to ensure full compliance with FDA 21 CFR Part 11, EU GMP Annex 11, and ISPE GAMP 5. The scope included system validation (CSV), legacy data migration, risk-based test planning, and documentation for audit readiness.

Challenges
  • Comprehensive IQ/OQ/PQ validation for GxP-critical Maximo workflows
  • Large-scale legacy data migration with integrity and audit trail requirements
  • High availability demands with minimal planned downtime
  • Regulatory scrutiny requiring traceable validation and electronic signatures
  • Limited QA/IT resources and pressure to meet aggressive deployment deadlines

Solution: AI-Driven Validation and Predictive Compliance

SQA Solution introduced a CSA-aligned, AI-enhanced validation model using on-premise deployments of ChatGPT (OpenAI GPT-4) and Google Gemini. This architecture ensured control, data privacy, and GxP auditability. By leveraging AI in test design, data integrity assurance, and documentation automation, the company accelerated validation and mitigated compliance risk.

AI Integration across CSV & CSA Activities

  1. Predictive Analytics (Gemini):

    • Analyzed legacy system logs and previous validation deviations
    • Predicted high-risk configuration scenarios in Maximo
    • Informed test prioritization under CSA principles
  2. Test Case Generation (ChatGPT):

    • Generated IQ, OQ, PQ test scripts based on URS, SOPs, and Maximo configuration
    • Reduced writing time and ensured alignment with validation templates
  3. Real-Time Anomaly Detection:

    • Flagged OQ issues such as permission mismatches, missing eSignatures, and audit trail failures
  4. Data Integrity Validation:

    • Gemini validated 2M+ legacy records for accuracy, completeness, and Part 11 compliance
    • Detected 92% of field-level anomalies before final ETL
  5. Documentation Automation:

    • AI generated traceability matrices, deviation logs, validation summary reports
    • Ensured full GAMP 5 and SOP alignment

Implementation Timeline

  • Weeks 1–4: CSA planning, AI deployment, SOP ingestion, risk assessment
  • Weeks 5–8: URS finalization, data profiling, and dry-run migration with predictive QA checks
  • Weeks 9–12: AI-driven test case generation and approval workflows
  • Weeks 13–16: IQ/OQ/PQ execution with AI-assisted scripts and real-time Gemini alerts
  • Weeks 17–20: Final documentation, stakeholder signoffs, and validation summary reports
  • Week 21: Go-live with zero critical validation issues

Results & Measurable Impact

  • 30% CSV timeline reduction (from 10 to 7 weeks)
  • 40% reduction in manual test case authoring
  • 100% data integrity across migrated records
  • 0 critical post-deployment incidents or audit findings
  • Fully traceable validation package aligned with regulatory expectations

Regulatory Alignment & Governance

The AI-assisted validation strategy aligned with:

  • FDA 21 CFR Part 11 (Electronic Records; Electronic Signatures)
  • EU GMP Annex 11 (Computerised Systems)
  • ISPE GAMP 5 (Risk-Based Approach)
  • ISPE GAMP Good Practice Guides (Data Integrity by Design, Testing)
  • FDA Draft CSA Guidance (2022)

All AI outputs were reviewed by SMEs, version-controlled, and governed via documented change control. AI tools were validated as configurable utilities, and all artifacts were fully audit-trail enabled.

 

Client Testimonial

We validated the AI just like any other critical system. What surprised us was how seamlessly it plugged into our CSA framework. We hit our timeline, reduced workload, and ended up with one of the cleanest go-lives I’ve seen in 20 years.

– Director of QA Validation, Top 10 Pharma Manufacturer

Case Studies
image
SQA Solution's Approach to 21 CFR Part 11 Compliance in a Global Healthcare Corporation

A global healthcare corporation faced significant challenges in complying with 21 CFR Part 11, especially section 11.10

    image
    Strategic SOP Development for Enhanced Infrastructure and Compliance for BioPharma

    Developing comprehensive SOPs in a biopharmaceutical context is fundamental for ensuring regulatory compliance, and maintaining high standards of quality and safety …

      image
      Comprehensive API Testing for a Leading Credit Manager in Commercial Real Estate Lending

      Before engaging our services, the client faced significant challenges in ensuring the reliability, security, and overall quality of their API functionalities …

        image
        SAP S/4 HANA GxP Compliance and Validation Project

        The objective is to align the SAP S/4 HANA system of a leading biopharma
        company with the stringent requirements of GxP regulations and
        21 CFR Part 11 …

          image
          SQA Solution Quality Systems and Compliance Consultant at a Biotechnology Company

          The consultant’s role is pivotal in ensuring the compliance of computerized systems with regulatory standards and internal policies.

            image
            Optimizing Software Quality and Performance for a Leading Multi-Channel Retailer

            The retailer required a robust software infrastructure to ensure seamless online shopping experiences and operational efficiency …

              Seeking Top-Tier Testing Talent?
              Let's Discuss Your Project!